Clinical Trial Update: Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice

View source ↗

Summary

A clinical trial evaluating non-immunogenic staphylokinase as reperfusion therapy for acute ischemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Non-immunogenic staphylokinase (staphylokinase)

Snippet

Sponsor: National Society for Neurosonology and Cerebral Circulation | Conditions: Acute Stroke | Status: RECRUITING